Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Androulakis

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|July 22, 2016
Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin CEmmanuel Androulakis, Nikolaos Papageorgiou, Eirini Lioudaki, et al.
Current Vascular Pharmacology|November 25, 2011
Lifestyle factors and endothelial functionNikolaos Papageorgiou, Dimitris Tousoulis, Emmanuel Androulakis, et al.
Journal of the American College of Cardiology|August 17, 2013
Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approachesDimitris Tousoulis, Nikolaos Papageorgiou, Emmanuel Androulakis, et al.
European Heart Journal. Cardiovascular Imaging|January 12, 2021
Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonanceAlexios S Antonopoulos, Alessia Azzu, Emmanuel Androulakis, et al.
Frontiers in Cardiovascular Medicine|January 7, 2022
The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Myocardial Fibrosis in Young and Veteran Athletes: Insights From a Meta-AnalysisEmmanuel Androulakis, Dimitrios Mouselimis, Anastasios Tsarouchas, et al.
Current Pharmaceutical Design|December 30, 2011
Pathophysiology of atherosclerosis: the role of inflammationDimitris Tousoulis, Anna-Maria Kampoli, Nikolaos Papageorgiou, et al.
Expert Opinion on Biological Therapy|December 6, 2017
Biological therapies targeting arrhythmias: are cells and genes the answer?Debbie Falconer, Nikolaos Papageorgiou, Emmanuel Androulakis, et al.
Reviews in Cardiovascular Medicine|July 14, 2021
Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablationCatrin Sohrabi, Syed Ahsan, Alexandros Briasoulis, et al.
Reviews in Cardiovascular Medicine|December 27, 2021
Extracorporeal veno-venous ultrafiltration in patients with acute heart failureAlberto Somaschini, Amanda Casirati, Stefano Cornara, et al.
Current Pharmaceutical Design|December 30, 2011
Inflammation in hypertension: current therapeutic approachesEmmanuel Androulakis, Dimitris Tousoulis, Nikolaos Papageorgiou, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Hypertension (Greenwich, Conn.)|July 22, 2016
Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin CEmmanuel Androulakis, Nikolaos Papageorgiou, Eirini Lioudaki, et al.
Current Vascular Pharmacology|November 25, 2011
Lifestyle factors and endothelial functionNikolaos Papageorgiou, Dimitris Tousoulis, Emmanuel Androulakis, et al.
Journal of the American College of Cardiology|August 17, 2013
Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approachesDimitris Tousoulis, Nikolaos Papageorgiou, Emmanuel Androulakis, et al.
European Heart Journal. Cardiovascular Imaging|January 12, 2021
Eosinophilic heart disease: diagnostic and prognostic assessment by cardiac magnetic resonanceAlexios S Antonopoulos, Alessia Azzu, Emmanuel Androulakis, et al.
Frontiers in Cardiovascular Medicine|January 7, 2022
The Role of Cardiovascular Magnetic Resonance Imaging in the Assessment of Myocardial Fibrosis in Young and Veteran Athletes: Insights From a Meta-AnalysisEmmanuel Androulakis, Dimitrios Mouselimis, Anastasios Tsarouchas, et al.
Current Pharmaceutical Design|December 30, 2011
Pathophysiology of atherosclerosis: the role of inflammationDimitris Tousoulis, Anna-Maria Kampoli, Nikolaos Papageorgiou, et al.
Expert Opinion on Biological Therapy|December 6, 2017
Biological therapies targeting arrhythmias: are cells and genes the answer?Debbie Falconer, Nikolaos Papageorgiou, Emmanuel Androulakis, et al.
Reviews in Cardiovascular Medicine|July 14, 2021
Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablationCatrin Sohrabi, Syed Ahsan, Alexandros Briasoulis, et al.
Reviews in Cardiovascular Medicine|December 27, 2021
Extracorporeal veno-venous ultrafiltration in patients with acute heart failureAlberto Somaschini, Amanda Casirati, Stefano Cornara, et al.
Current Pharmaceutical Design|December 30, 2011
Inflammation in hypertension: current therapeutic approachesEmmanuel Androulakis, Dimitris Tousoulis, Nikolaos Papageorgiou, et al.
Pageof 8